Positive Peers Intervention Clinical Trial
Recruiting now · Not applicable
Conditions studied: HIV Infections
In brief
The goal of this clinical trial is to learn if the Positive Peers mobile app intervention increases rates of viral suppression in young (13-34 y/o) persons with HIV. Does use of the Positive Peers app improve viral suppression among young minority persons with HIV? What user characteristics are associated with a) viral suppression, b) retention in care, and c) perceived HIV-related stigma? Participants will: * download the mobile app onto their personal smartphone * Use the mobile app as they find useful * complete online surveys at enrollment, 3 mo, 6, mo, 9 mo and 12 months.
Key facts
- Study ID
- NCT06388109
- Run by
- MetroHealth Medical Center
- People needed
- 250
- Starts
- 2024-06-03
- Expected to finish
- 2027-11-01
- Last updated by the study team
- 2025-10-15
Who can join
Age: 13 and older, up to 34. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- HIV+
- Identifies as either a racial, ethnic, sexual or gender minority
- One of the following:
- Newly diagnosed within last 12 months
- Out of care (greater than 6 months between any two HIV provider visits in last 24 months)
- Not virally suppressed (any viral load > 200 copies in last 24 months)
- Has a working smartphone
- Functional English ability
You may not qualify if…
- prior use of Positive Peers mobile app
Where it is running
- Northeast Valley Health Corporation — Van Nuys, California, United States (enrolling)
- Infectious Disease Practice- Rutgers University — Newark, New Jersey, United States (enrolling)
- Equitas Health — Cincinnati, Ohio, United States (enrolling)
- Equitas Health — Columbus, Ohio, United States (enrolling)
- Thomas Street Clinic — Houston, Texas, United States (enrolling)
- UW Madison Clinic at Harborview — Seattle, Washington, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.